CClinicalTrials.gg
CompletedNCT05840081Updated Dec 12, 2025

Dairy Fat and Fermentation Study

An interventional study of Milk or yogurt beverage in Heart Diseases, Microbial Colonization and Inflammation, sponsored by Tufts University. Completed at 1 site in United States. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-12.

Sponsored by Tufts University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The purpose of the study is to compare the effect of consuming full-fat (regular) and fat-free (skim) milk, as well as full-fat and fat-free yogurt (a fermented dairy product), on microorganisms in your gut as well as the products produced by the gut microbes. We will also determine whether consuming these dairy products affects risk factors for heart disease.The findings of the study will help us determine if heart disease risk factors are modified by the fat content and fermentation of milk. The results may facilitate refinement of public health dietary guidance for cardiovascular disease risk reduction.

Read the detailed description

A randomized-controlled cross-over trial will be conducted to compare the effect of two servings per day of full-fat and fat-free milk, and full-fat and fat-free yogurt (hence forth referred to as dairy food items) on the gut microbiome, fecal and serum metabolome, and determine their relation to cardiometabolic risk factors (CMRF) and functional pathways associated with the differences identified. Participants will be provided with 2 servings per day of the test dairy products and requested not to consume additional bovine (cow) milk or yogurt during each 3-week diet phase.They will be allowed to use dairy substitutes such as plant-based milk alternatives and consume other types of dairy products (e.g. cheese).

The study consists of four diet phases: fat-free milk phase, full-fat milk phase, fat-free yogurt phase and full-fat yogurt phase. Each diet phase is 3 weeks in duration, separated by a 2 week break. Participants will be provided with 2 servings of a dairy based food item per day specific to their assigned phase and asked to consume them at two separate times during the day - morning and evening. Weight, waist circumference and blood pressure will be measured, blood and stool samples will be collected, and participants will complete two 24-hr food recall questionnaires during each phase.

02

Conditions studied

  • Heart Diseases
  • Microbial Colonization
  • Inflammation

Keywords

  • gut microbiome
  • gut microbiota
  • yogurt
  • milk
  • heart disease
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's enrollment of 37 is below the median of 100 across 1,778 interventional studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

Tufts University is the lead sponsor of 225 studies on the registry; 24 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 7 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Age >50 years
  2. Men and postmenopausal women
  3. BMI >25 and \<35 kg/m2
  4. No milk allergy, lactose intolerance or adherence to vegan or other dietary pattern that excludes dairy products
  5. Non-smoker
  6. Usual pattern of bowel movements at least every other day.

Exclusion criteria

Exclusion Criteria:

  1. Women and men \<50 years
  2. Women, pre- or peri-menopausal
  3. BMI \<25 and >35 kg/m2
  4. Current smokers or former smoker who quit \< 6 months
  5. Use of nicotine replacement products within last 6 months
  6. Replacement or gender affirming hormonal therapy use
  7. Weight gain of >15 pounds within last 6 months
  8. Infrequent bowel movements
  9. History of anemia within past 2 years or confirmation of anemia at first study visit
  10. Blood donation within last 2 months
  11. Untreated hypertension
  12. Oral antibiotics use within 2 weeks of study entry
  13. Steroid use (including dental prophylaxis use within 2 wks prior to or during study, except non-prescription topical and nasal steroids, e. g. Flonase)
  14. Use of lipid lowering medications
  15. Chronic use of aspirin, non-steroidal anti-inflammatory medications (NSAIDS), laxatives, anti-diarrheal medication
  16. Regular use (>2 times per week) of acid lowering medication: antacids, proton pump inhibitors, or H2 Blockers.
  17. Use of dietary supplements other than multi-vitamins, including pre- and probiotics, within 2 months of study entry
  18. Milk allergy, lactose intolerance or adherence to vegan or other dietary patterns that exclude dairy products
  19. Colonoscopy within 3 weeks of study entry or during study period
  20. Diagnosis of malabsorption, inflammatory bowel disease (ulcerative colitis or Crohn's Disease), cirrhosis, history of gastrointestinal resection (other than appendectomy), chronic pancreatitis or any other chronic GI disease that in the opinion of the study physician would alter the study results
  21. Chronic heart, liver, thyroid, renal or kidney disease
  22. Type I or type II diabetes
  23. Alcohol consumption >7 drinks/week for women and >14 drinks/week for men
  24. Inadequate refrigerator storage capacity to store 21 8-oz containers of milk or yogurt
  25. Participation in other dietary intervention research study during the same time
  26. No social security number
  27. Not willing to commit to adhering to the protocol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
37 participants (actual)

Study arms

  • Experimental
    Full-fat milk beverage

    Beverage made with full-fat milk

    Other: Milk or yogurt beverage

  • Experimental
    Fat-free milk beverage

    Beverage made with fat-free milk

    Other: Milk or yogurt beverage

  • Experimental
    Full-fat yogurt beverage

    Beverage made with full-fat yogurt

    Other: Milk or yogurt beverage

  • Experimental
    Fat-free yogurt beverage

    Beverage made with fat-free yogurt

    Other: Milk or yogurt beverage

Interventions

  • OtherMilk or yogurt beverage

    Commercially available milk or yogurt (depending on experimental arm) will be incorporated into flavored drinks/smoothies to minimize perceived differences among these items, preserving the double-blind nature of the study design.

06

What researchers measure

Primary outcomes

  1. gut microbiome

    Determine the effects of dairy fat in milk, with and without fermentation, on gut microbiome

    Time frame: 3 weeks

  2. fecal metabolome

    Determine the effects of dairy fat in milk, with and without fermentation, on fecal metabolome

    Time frame: 3 weeks

  3. serum metabolome

    Determine the effects of dairy fat in milk, with and without fermentation, on serum metabolome

    Time frame: 3 weeks

07

Study locations

1 site
  • Jean Mayer Human Nutrition Research Center on Aging
    Boston, Massachusetts 02111, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05840081
Lead sponsor
Tufts University
Responsible party
Alice Lichtenstein (D.Sc., Tufts University) — Principal investigator
First posted
May 3, 2023
Start date
Oct 1, 2023
Primary completion
Aug 19, 2025
Completion
Aug 19, 2025
Last update
Dec 12, 2025

Study contacts

Alice H Lichtenstein, D. Sc.
principal investigator · Tufts University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion